InvestorsHub Logo
Followers 120
Posts 20750
Boards Moderated 0
Alias Born 06/13/2011

Re: Cosa post# 14067

Thursday, 11/04/2021 7:26:34 PM

Thursday, November 04, 2021 7:26:34 PM

Post# of 17454
This will not go to 0 (if there is no deal )
Lupkynis is an important new drug that will slow progression to dialysis for CKD patients with severe LN .

If BP and AUPH can not come to terms then AUPH will GIA and experience a cash drain in the first year or so … but Lupkynis will eventually be used by many with severe LN because it’s cost effective re dialysis costs ( $120k a yr ) … let alone what life is like for dialysis patients —- up to 4 hrs a day ,3 days a week on a machine cleaning your blood .

Am I the only one here who has actually been on a dialysis floor ?

Kiwi
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News